NPR’s Marketplace morning featured two stories today on the launch of GSK’s over-the-counter weight loss drug alli. One of these stories featured Prescription Access Litigation director Alex Sugerman-Brozan discussing alli and why it should not be available over-the-counter. A streaming version of the story can be found here.